ArticleClinical journal of gastroenterology2023

Successful second conversion surgery after trastuzumab deruxtecan for recurrent HER2-positive gastric cancer.

Takeshi Terashima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.